Where can researchers source third-party tested Cagrilintide?

Midwest Peptide supplies research-grade Cagrilintide with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Memorial Day: 15% off code MEMDAY15Memorial Day Sale — 15% off site-wide with code MEMDAY15

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

Amylin Receptor Research: Biology Studies | Midwest Peptide

Cagrilintide Satiety Studies: Animal Model Research on Food IntakePrev|Cagrilintide in Research: A Review of Long-Acting Amylin Analog StudiesNext

Amylin Receptor Research: Biology and the Foundation for Cagrilintide Studies

Cagrilintide · Published April 8, 2026 · Updated May 18, 2026 · 9 min read

Quick Answer

Amylin receptor research covers the calcitonin receptor combined with RAMP proteins to form AMY1, AMY2, and AMY3 complexes that mediate amylin signaling. This foundation explains the receptor architecture, signaling pathways, and tissue distribution underlying cagrilintide and other amylin analog research. For research use only, not for human consumption.

Amylin Receptor Research: Biology and the Foundation for Cagrilintide Studies

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

What Is the Amylin Receptor?
RAMP Biology in Research
Amylin Receptor Signaling Pathways
Tissue Distribution of the Amylin Receptor System
Amylin Receptor Pharmacology and Selectivity
Amylin and the Calcitonin Family
Open Research Questions
Conclusion
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

Amylin receptor research provides the mechanistic foundation for the entire body of preclinical work on amylin and its analogs, including cagrilintide. The amylin receptor is a unique pharmacological entity formed from the combination of the calcitonin receptor with receptor activity modifying proteins (RAMPs), and its complex pharmacology is one of the more conceptually interesting topics in the broader peptide receptor literature. As the receptor biology component of the cagrilintide research cluster, this article reviews the published literature on amylin receptor structure, signaling, tissue distribution, and the mechanism of action that underlies cagrilintide research in animal models.

Frequently Asked Questions

What is Cagrilintide in research contexts?

Cagrilintide is a long-acting synthetic amylin analog modified for extended half-life. It is studied in preclinical research models for its effects on satiety, gastric emptying, food intake, and body composition through amylin and calcitonin receptor signaling.

What is the structure of the amylin receptor?

The amylin receptor is a heterodimer of the calcitonin receptor (CTR) with one of three RAMP proteins (RAMP1, RAMP2, RAMP3), forming AMY1, AMY2, and AMY3 receptor subtypes with distinct tissue distribution and signaling properties.

Why is amylin receptor biology foundational to Cagrilintide research?

Cagrilintide acts on the same calcitonin and amylin receptor family, so understanding receptor architecture, RAMP-defined selectivity, and tissue distribution is essential for interpreting Cagrilintide pharmacology in research models.

Is Cagrilintide approved for human use?

No. Cagrilintide is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Glossary

Key terms used in this article.

Amylin: A 37-amino-acid peptide hormone co-secreted with insulin from pancreatic beta cells, involved in postprandial glucose regulation and satiety.
Calcitonin Receptor: The class B GPCR that, when complexed with RAMP proteins, forms functional amylin receptors AMY1, AMY2, and AMY3.
RAMP: Receptor activity-modifying proteins (RAMP1, RAMP2, RAMP3) that combine with the calcitonin receptor to define amylin receptor subtypes.
Satiety: The sensation of fullness following food intake, regulated by gut peptides, central nervous system signaling, and hormonal cues.
CagriSema: A research combination of cagrilintide and semaglutide studied for amylin and GLP-1 pathway synergy.
AMY1 Receptor: Calcitonin receptor + RAMP1 heterodimer, the dominant amylin receptor subtype in the area postrema.
Area Postrema: A circumventricular brainstem region with a permeable blood-brain barrier where amylin acts to suppress food intake.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. Cagrilintide and the broader research compounds discussed in this article are intended exclusively for in vitro and preclinical research. They are not approved for human use, are not drugs, and should never be administered to humans or to animals outside of an authorized research protocol.

What Is the Amylin Receptor?

The amylin receptor is not a single conventional receptor but rather a heterodimeric complex formed by the association of the calcitonin receptor with one of three receptor activity modifying proteins (RAMPs). The calcitonin receptor itself is a class B G protein coupled receptor that, in isolation, binds calcitonin with high affinity. However, when the calcitonin receptor is co-expressed with RAMP1, RAMP2, or RAMP3, the resulting complexes have dramatically different binding profiles for the calcitonin family peptides, including amylin.

The three amylin receptor complexes are designated AMY1, AMY2, and AMY3 based on which RAMP is involved. AMY1 is formed from the calcitonin receptor plus RAMP1, AMY2 from the calcitonin receptor plus RAMP2, and AMY3 from the calcitonin receptor plus RAMP3. Each of these complexes has its own selectivity profile for amylin and related peptides, and this complex pharmacology is one of the more conceptually interesting features of the amylin system in preclinical research.

The discovery that RAMPs could fundamentally change the binding properties of a GPCR was a significant conceptual advance in receptor pharmacology research. It demonstrated that receptor selectivity is not solely determined by the receptor protein itself but can be modified by accessory proteins that associate with it. This finding has informed the broader research literature on G protein coupled receptor function and has implications for how researchers think about pharmacological selectivity in cellular contexts.

RAMP Biology in Research

Receptor activity modifying proteins are single transmembrane domain proteins that associate with certain class B GPCRs and modify their pharmacology. The three RAMPs (RAMP1, RAMP2, and RAMP3) were originally identified in research on the calcitonin gene related peptide (CGRP) receptor, where they were shown to be required for surface expression and proper ligand binding. Subsequent research extended the RAMP concept to other class B GPCRs, including the calcitonin receptor (which forms the amylin receptor complexes when associated with RAMPs), the glucagon receptor, the GLP-1 receptor (in some specialized contexts), and others.

The molecular basis for RAMP-mediated changes in receptor pharmacology involves direct interactions between the RAMP and the extracellular ligand binding domain of the receptor. These interactions modify the conformation of the binding pocket and alter which ligands can bind with high affinity. In the case of the calcitonin receptor, the addition of a RAMP shifts the binding preference from calcitonin to amylin, producing the amylin receptor complexes.

Research on RAMP biology has used a combination of biochemical assays, structural studies, and cellular pharmacology to characterize how the RAMPs modify receptor function. The published findings have established the conceptual framework for understanding amylin receptor pharmacology and have informed the development of selective ligands like cagrilintide and pramlintide.

Amylin Receptor Signaling Pathways

Amylin binding at the amylin receptor complexes activates the canonical Gs alpha pathway, leading to coupling with adenylyl cyclase, increases in intracellular cyclic AMP, and downstream activation of protein kinase A. This signaling cascade is the primary route by which amylin produces its cellular and physiological effects in research models.

Beyond the canonical Gs alpha pathway, amylin receptor activation also involves additional signaling pathways that contribute to its overall activity. These include coupling to other G protein subunits in some tissue contexts, recruitment of beta-arrestin signaling, and downstream effects on extracellular signal regulated kinase (ERK) and other intracellular signaling cascades. The relative contributions of these different pathways depend on the cellular context and on which AMY complex is involved.

The signaling pathways downstream of the amylin receptor have been characterized in cell culture systems using pharmacological agonists, antagonists, and genetic manipulations of the calcitonin receptor and the RAMPs. These studies provide the experimental foundation for understanding how amylin receptor agonists like cagrilintide produce their effects in research models.

Tissue Distribution of the Amylin Receptor System

The components of the amylin receptor system are expressed in multiple tissues throughout the body, and their distribution is a key factor in understanding how amylin and amylin analogs produce their effects in research models. The most important site of expression for satiety related research is the brainstem, particularly the area postrema, which is one of the few brain regions where the blood brain barrier is permeable to peripheral peptides. The area postrema expresses the calcitonin receptor and the RAMPs, allowing amylin and amylin analogs to act there directly to influence satiety signaling.

Other regions of the central nervous system also express amylin receptor components, including the nucleus of the solitary tract, the lateral parabrachial nucleus, and various forebrain regions involved in appetite regulation and feeding behavior. The pattern of expression provides multiple sites at which amylin signaling can integrate with other satiety regulating pathways in research models.

Peripheral tissue expression of amylin receptor components has been characterized in the kidney, in vascular smooth muscle, in osteoclasts, and in additional tissues where amylin or related peptides may have functional effects. The peripheral effects of amylin receptor activation in these tissues have been studied for their contributions to the broader research profile of amylin analogs.

For more on how the central effects translate to feeding behavior research, see our companion article on Cagrilintide satiety studies and animal model research.

Amylin Receptor Pharmacology and Selectivity

The selectivity of different amylin analogs across the AMY1, AMY2, and AMY3 receptor complexes is one of the more important features for research applications. Different analogs can show different binding profiles, with implications for which downstream pathways they activate most strongly in research models.

Natural amylin shows preferential binding at AMY1 and AMY3, with somewhat lower affinity at AMY2. Pramlintide, the older amylin analog, has a similar preference for AMY1 and AMY3. Cagrilintide and other long-acting amylin analogs have been characterized for their binding profiles at these complexes, with the published findings informing how the analogs are used as research tools in specific contexts.

The selectivity profile is functionally important because the AMY1, AMY2, and AMY3 complexes have somewhat different tissue distributions and downstream signaling characteristics. An analog that binds preferentially to one complex over another may produce a slightly different research profile than one that binds all three equally, although in practice the differences between the major amylin analogs are relatively subtle compared to the differences between amylin analogs and other peptide receptor agonists.

Amylin and the Calcitonin Family

The amylin receptor complexes are part of a broader family of receptors that respond to the calcitonin family of peptides. The calcitonin family includes calcitonin itself, amylin, calcitonin gene related peptide (CGRP), and adrenomedullin. Each of these peptides has its preferred receptor or receptor complex, but there is some cross-reactivity between the family members at related receptors.

This family relationship is one of the reasons amylin receptor research has connections to broader research on the calcitonin family. Studies of CGRP receptors, calcitonin receptors, and amylin receptors all contribute to the overall understanding of how the calcitonin family of peptides regulates physiological processes in research models. The shared use of RAMPs across some of these receptor complexes adds a level of conceptual unity to the system.

Open Research Questions

Several open research questions remain in amylin receptor pharmacology. These include how the structural details of amylin receptor activation captured by recent crystal structures translate to functional differences between amylin analogs, how the selectivity profiles of cagrilintide and other long-acting analogs compare quantitatively across the AMY1, AMY2, and AMY3 complexes, and how the integration of amylin receptor signaling with other satiety regulating pathways produces the observed effects on food intake in research models. Each of these is a legitimate research opportunity for investigators studying amylin receptor pharmacology.

Conclusion

Amylin receptor research provides the mechanistic foundation for understanding cagrilintide and the broader class of amylin receptor agonists studied in preclinical models. The unique receptor complex architecture formed from the calcitonin receptor and RAMPs, the tissue distribution that includes the area postrema and other brain regions involved in satiety signaling, and the canonical Gs alpha signaling pathway that produces the cellular effects of amylin all combine to make the amylin receptor system one of the more conceptually rich areas of class B GPCR research. For investigators using Cagrilintide 10mg as a research tool, the receptor pharmacology literature provides essential context for experimental design.

For more on the full cagrilintide research cluster, see the pillar overview article and the supporting articles on each major topic.

Cagrilintide is supplied by Midwest Peptide for research use only and is not intended for human administration.

Explore more peer-reviewed research and laboratory guides from our science team:

All products are third-party tested with a Certificate of Analysis (COA) included. For research use only.

GLP-1 SM 20mg, 99%+ purity, COA included
Cagrilintide 10mg, 99%+ purity, COA included
BPC-157 10mg, 99%+ purity, COA included

Browse All Research Peptides →

Age Verification

Amylin Receptor Research: Biology and the Foundation for Cagrilintide Studies

Frequently Asked Questions

What is Cagrilintide in research contexts?

What is the structure of the amylin receptor?

Why is amylin receptor biology foundational to Cagrilintide research?

Is Cagrilintide approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

What Is the Amylin Receptor?

RAMP Biology in Research

Amylin Receptor Signaling Pathways

Tissue Distribution of the Amylin Receptor System

Amylin Receptor Pharmacology and Selectivity

Amylin and the Calcitonin Family

Open Research Questions

Conclusion

Ready to Start Your Research?

Where can researchers source third-party tested Cagrilintide?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?

Age Verification

Amylin Receptor Research: Biology and the Foundation for Cagrilintide Studies

Frequently Asked Questions

What is Cagrilintide in research contexts?

What is the structure of the amylin receptor?

Why is amylin receptor biology foundational to Cagrilintide research?

Is Cagrilintide approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

What Is the Amylin Receptor?

RAMP Biology in Research

Amylin Receptor Signaling Pathways

Tissue Distribution of the Amylin Receptor System

Amylin Receptor Pharmacology and Selectivity

Amylin and the Calcitonin Family

Open Research Questions

Conclusion

Related Research Articles

Explore Related Products

Ready to Start Your Research?

Where can researchers source third-party tested Cagrilintide?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?